Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

Por Rudin, Charles M., Poirier, John T., Senzer, Neil N., Stephenson, Joseph, Loesch, David, Burroughs, Kevin D., Reddy, P. Seshidhar, Hann, Christine L., Hallenbeck, Paul L.
Publicado no Clin Cancer Res (2011)

Structural Features of the Seneca Valley Virus Internal Ribosome Entry Site (IRES) Element: a Picornavirus with a Pestivirus-Like IRES

Por Willcocks, Margaret M., Locker, Nicolas, Gomwalk, Zarmwa, Royall, Elizabeth, Bakhshesh, Mehran, Belsham, Graham J., Idamakanti, Neeraja, Burroughs, Kevin D., Reddy, P. Seshidhar, Hallenbeck, Paul L., Roberts, Lisa O.
Publicado em 2011

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

Por Reddy, P. Seshidhar, Burroughs, Kevin D., Hales, Laura M., Ganesh, Shanthi, Jones, Brian H., Idamakanti, Neeraja, Hay, Carl, Li, Shawn S., Skele, Kristine L., Vasko, Ann-Jeanette, Yang, Jingping, Watkins, D. Neil, Rudin, Charles M., Hallenbeck, Paul L.
Publicado no J Natl Cancer Inst (2007)

Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter

Por Gavrin, Lori K., Mahaney, Paige E., Jenkins, Douglas, Nogle, Lisa M., Mugford, Cheryl A., Huselton, Christine, Leiter, Jennifer, Johnston, Grace H., Bray, Jenifer A., Burroughs, Kevin D., Cosmi, Scott A., Alfinito, Peter, Ho, Douglas M., Deecher, Darlene C., Trybulski, Eugene J.
Publicado em 2010